Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Non-cash Items: 2018-2024

  • Fennec Pharmaceuticals' Non-cash Items was N/A to $5.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is N/A change from last year.
  • Fennec Pharmaceuticals' Non-cash Items amounted to $5.0 million in Q4 2024, which was down 74.18% from $19.4 million recorded in Q4 2018.
  • Over the past 5 years, Fennec Pharmaceuticals' Non-cash Items peaked at $5.0 million during Q4 2024, and registered a low of $5.0 million during Q4 2024.
  • Moreover, its 1-year median value for Non-cash Items was $5.0 million (2024), whereas its average is $5.0 million.